Cambridge Enterprise Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
TRIMTECH Therapeutics lands an £11m seed extension led by JJDC and BGF to degrade toxic proteins linked to Alzheimer's and other neurodegenerative diseases
TRIMTECH Therapeutics is a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases. Its TRIMTAC and TRIMGLUE platforms are designed to selectively degrade toxic protein aggregates and oligomers whilst leaving functional monomeric forms of those proteins intact to support healthy cellular function.
Houdini Bio launches with a £1.5m pre-seed led by SCVC to tackle gene silencing with machine learning DNA design platform
Houdini Bio has built a machine learning-guided DNA sequence design platform that re-engineers therapeutic DNA to evade the Human Silencing Hub (HUSH) complex, a cellular defence mechanism that mistakes gene therapies for viral invaders and shuts them down. The platform is designed for gene and cell therapy developers seeking to improve long-term efficacy, reduce required doses and lower manufacturing costs.
Gigaton announces £20m Series A led by Plural to replace industrial control stack with self-learning AI software
Gigaton builds autonomous, self-learning AI control software for energy-intensive industries including cement, steel, glass, and chemicals. Its platform replaces existing control systems, simulating process behaviour and adjusting key parameters in real time to reduce fuel costs and cut emissions.
Barocal raises £7.4m from VCs to develop solid state cooling and heating systems without refrigerant gases
Barocal is a Cambridge University spinout developing solid-state cooling and heating systems using pressure-driven materials. The technology replaces refrigerant gas systems and is designed for applications including data centre cooling and commercial refrigeration.
auryx raises £1.5m pre-seed round led by Celero Ventures to turn ordinary earbuds into health monitors
auryx builds a platform that uses sound from microphones in devices such as earbuds to measure physiological signals. It enables continuous health monitoring without additional sensors or changes in user behaviour.
Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery
Semarion develops cell assay technology that enables adherent cell models to be handled as assay-ready, barcoded reagents. Its platform is used by pharmaceutical and life sciences organisations to improve flexibility, scalability and data generation in drug discovery workflows.
xWatts lands a £1.6m seed round led by Cambridge Enterprise Ventures to decarbonise complex real estate
xWatts builds an energy management platform that connects to building systems and optimises performance in real time. It helps complex estates reduce energy consumption and carbon emissions through automated control.
Sparxell raises £3.7m in funding led by SWEN Capital Partners to replace toxic chemicals with plant-based colour technology
Sparxell develops plant-based structural colour materials as alternatives to synthetic dyes and pigments. It manufactures cellulose-based colourants for use in textiles, cosmetics and other consumer products.
Cambridge Photon Technology raises £1.6m in funding led by Cambridge Enterprise to turn unused light into usable power
Cambridge Photon Technology builds photon-multiplier materials that increase the efficiency of standard silicon solar panels by converting wasted high energy light into usable power without changing existing manufacturing processes.
NoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horses
NoBACZ Healthcare develops antibiotic-free liquid bandage technology for livestock and horses, creating protective wound coatings that reduce infection risk in agricultural environments.
Trismik secures £2.2m pre-seed led by Twin Path Ventures to launch tools for designing and analysing LLM experiments
Trismik provides tools for evaluating large language models using adaptive testing, helping AI teams measure capability, safety and reasoning more accurately while reducing the cost and time of traditional benchmarking.
Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
More venture news
- 21 Jul 2026
Mach42Mach42 raises a £7m pre-Series A round led by IP Group to speed up analog circuit verification for semiconductor engineers
ExtensionDeep Tech - 9 Jul 2026
Alchemab TherapeuticsAlchemab Therapeutics secures £25m Series A extension from British Business Bank to scale antibody drug discovery pipeline for hard-to-treat diseases
ExtensionLife Sciences - 23 Jun 2026
TRIMTECH TherapeuticsTRIMTECH Therapeutics lands an £11m seed extension led by JJDC and BGF to degrade toxic proteins linked to Alzheimer's and other neurodegenerative diseases
ExtensionLife Sciences
